1. MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo.
- Author
-
Heidenreich O, Neininger A, Schratt G, Zinck R, Cahill MA, Engel K, Kotlyarov A, Kraft R, Kostka S, Gaestel M, and Nordheim A
- Subjects
- 3T3 Cells, Animals, Arsenites pharmacology, Calcium-Calmodulin-Dependent Protein Kinases metabolism, Fibroblasts drug effects, Fibroblasts metabolism, HeLa Cells, Humans, Intracellular Signaling Peptides and Proteins, Mice, Phosphorylation, Serine metabolism, Serum Response Factor, Signal Transduction drug effects, Teratogens pharmacology, p38 Mitogen-Activated Protein Kinases, DNA-Binding Proteins metabolism, Mitogen-Activated Protein Kinases, Nuclear Proteins metabolism, Protein Serine-Threonine Kinases metabolism
- Abstract
Several growth factor- and calcium-regulated kinases such as pp90(rsk) or CaM kinase IV can phosphorylate the transcription factor serum response factor (SRF) at serine 103 (Ser-103). However, it is unknown whether stress-regulated kinases can also phosphorylate SRF. We show that treatment of cells with anisomycin, arsenite, sodium fluoride, or tetrafluoroaluminate induces phosphorylation of SRF at Ser-103 in both HeLa and NIH3T3 cells. This phosphorylation is dependent on the kinase p38/SAPK2 and correlates with the activation of MAPKAP kinase 2 (MK2). MK2 phosphorylates SRF in vitro at Ser-103 with similar efficiency as the small heat shock protein Hsp25 and significantly better than CREB. Comparison of wild type murine fibroblasts with those derived from MK2-deficient mice (Mk(-/-)) reveals MK2 as the major SRF kinase induced by arsenite. These results demonstrate that SRF is targeted by several signal transduction pathways within cells and establishes SRF as a nuclear target for MAPKAP kinase 2.
- Published
- 1999
- Full Text
- View/download PDF